Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited - pharma in Daskroi, Gujarat, India. FY 2026 financials and compliance.
CIN U24304GJ2018PLC103796 Incorporated 31 August 2018 ROC Ahmedabad HQ Daskroi, Gujarat, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹98.31 Cr
▲ 48.00% YoY
EBITDA · FY 2025
*****
▲ 55.00% YoY
Net profit · FY 2025
*****
▲ 86.00% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹15 Cr
Issued & subscribed
Open charges
₹33.83 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
31
Latest available

About Claroid Pharmaceuticals Limited

Data last updated: 09 January 2026

Claroid Pharmaceuticals Limited is a public limited company based in Daskroi, Gujarat, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 August 2018, the company has been in operation for over 8 years.

Registered with ROC Ahmedabad under CIN U24304GJ2018PTC103796.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹15 Cr. It is led by directors including Rushin Baijubhai Desai and Arpankumar Patel.

Last AGM: 31 July 2025. Financial statements filed for year ended 31 March 2025. Office: Daskroi, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹98.31 Cr, a growth of 48% compared to the previous year.

The company has a workforce of approximately 31 employees as per the latest available data.

The company is associated with 1 brand - Claroid Pharmaceuticals. As per MCA filings, the company has open charges of ₹33.83 Cr on record.

For more details, the company can be reached via its website claroidpharma.com.

Company Details of Claroid Pharmaceuticals Limited
CIN U24304GJ2018PLC103796
Registration Number 103796
Incorporation Date 31 August 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Rushin Baijubhai Desai Whole-Time Director Snehalkumar Hasmukhlal Soni Whole-Time Director Shailesh Arjanbhai Patel Whole-Time Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    S.No – 217/P Opp Gurukul English School, Kamod – Pirana Road, Daskroi, Gujarat, India – 382425
  • Industry
    Pharma, Drug Formulation & Development
Company report
Claroid Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Claroid Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Claroid Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U24304GJ2018PTC103796. The current CIN is U24304GJ2018PLC103796, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24304GJ2018PLC103796 Current
U24304GJ2018PTC103796 Previous

Associated Brands with Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited operates one associated brand: Claroid Pharmaceuticals. These brands represent Claroid Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
Claroid Pharmaceuticals
Pharmaceutical manufacturing and innovative medicine development in India. claroidpharma.com

Business Activity of Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Board of Directors of Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited is currently managed by 10 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rushin Baijubhai Desai Whole-Time Director 31 Aug 2018 7 Years 10 Months Current
Arpankumar Patel Director 28 Apr 2025 1 Years 2 Months Current
Ghanshyam Arjanbhai Patel
Also directs: Accent Microcell Limited, Accent Biosciences Private Limited
Director 31 Aug 2018 7 Years 10 Months Current
Snehalkumar Hasmukhlal Soni
Also directs: Brohks Healthcare Private Limited
Whole-Time Director 31 Aug 2018 7 Years 10 Months Current
Shailesh Arjanbhai Patel Whole-Time Director 31 Aug 2018 7 Years 10 Months Current
Shashwat Yatishkumar Shah
Also directs: Indo Smc Limited
Director 28 Apr 2025 1 Years 2 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Claroid Pharmaceuticals Limited FY 2025 filings available

Claroid Pharmaceuticals Limited reported revenue of ₹98.31 Cr (up 48% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹98.31 Cr ▲ 48%
Profit
***** ▲ 86%
EBITDA
***** ▲ 55%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Claroid Pharmaceuticals Limited

Open charges
₹33.83 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹33.83 Cr
Latest charge details
DateLenderAmountStatus
03 Feb 2020 Hdfc Bank Limited ₹33.83 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Claroid Pharmaceuticals Limited

View historical data on people associated with Claroid Pharmaceuticals Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Claroid Pharmaceuticals Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Claroid Pharmaceuticals Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Claroid Pharmaceuticals Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Claroid Pharmaceuticals Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Claroid Pharmaceuticals Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Claroid Pharmaceuticals Limited

MSME Payment Delays by Claroid Pharmaceuticals Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Claroid Pharmaceuticals Limited

Subsidiaries & Group Companies of Claroid Pharmaceuticals Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Claroid Pharmaceuticals Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Claroid Pharmaceuticals Limited

MCA Filings & Documents of Claroid Pharmaceuticals Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Claroid Pharmaceuticals Limited

Directors
02 Aug 2025
Megha Parikh was appointed as a Company Secretary on 02 Aug 2025 & has been associated with this company since 11 months 7 days.
Activity
31 Jul 2025
Claroid Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Directors
19 Jun 2025
Baiju Bhupendrabhai Desai was appointed as a Cfo on 19 Jun 2025 & has been associated with this company since 1 year 20 days.
Directors
20 May 2025
Baiju Bhupendrabhai Desai was appointed as a CFO on 20 May 2025 & has been associated with this company since 1 year 1 month.
Directors
28 Apr 2025
Arpankumar Patel was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 2 months.
Directors
28 Apr 2025
Shashwat Yatishkumar Shah was appointed as a Director on 28 Apr 2025 & has been associated with this company since 1 year 2 months.

Frequently Asked Questions about Claroid Pharmaceuticals Limited

Claroid Pharmaceuticals Limited is an active public limited company in the pharma sector based in Daskroi, Gujarat, India. It was incorporated on 31 August 2018 (8+ years old) and is registered under CIN U24304GJ2018PLC103796. The company has 31 employees.

Claroid Pharmaceuticals Limited reported revenue of ₹98.31 Cr for FY 2025 (up 48.00% YoY).

The current directors of Claroid Pharmaceuticals Limited are:

The primary industry of Claroid Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Claroid Pharmaceuticals Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Claroid Pharmaceuticals Limited can be reached at the registered office: S.No – 217P Opp Gurukul English School, Kamod – Pirana Road, Daskroi, Gujarat, India – 382425, or through the website claroidpharma.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available